Splenomegaly (SPML) in polycythemia vera (PV): its clinical significance and its relation to symptoms, post-polycythemic myelofibrosis (PPMF) and survival.

Silver, Richard T; Erdos, Katie; Taylor, Elwood; Scandura, Joseph M; Abu-Zeinah, Ghaith

Silver, Richard T; Erdos, Katie; Taylor, Elwood; Scandura, Joseph M; Abu-Zeinah, Ghaith.

Afiliación

Silver RT; Richard T Silver, MD Myeloproliferative Neoplasms Center, Division of Hematology-Oncology, Weill Cornell Medicine, New York, NY, USA. rtsilve@med.cornell.edu.
Erdos K; Richard T Silver, MD Myeloproliferative Neoplasms Center, Division of Hematology-Oncology, Weill Cornell Medicine, New York, NY, USA.
Taylor E; Richard T Silver, MD Myeloproliferative Neoplasms Center, Division of Hematology-Oncology, Weill Cornell Medicine, New York, NY, USA.
Scandura JM; Richard T Silver, MD Myeloproliferative Neoplasms Center, Division of Hematology-Oncology, Weill Cornell Medicine, New York, NY, USA.
Abu-Zeinah G; Richard T Silver, MD Myeloproliferative Neoplasms Center, Division of Hematology-Oncology, Weill Cornell Medicine, New York, NY, USA.

Leukemia ; 37(3): 691-694, 2023 03.

Article en En | MEDLINE | ID: mdl-36550213

Asunto(s)

Policitemia Vera; Mielofibrosis Primaria; Humanos; Esplenomegalia/etiología; Relevancia Clínica; Janus Quinasa 2

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Policitemia Vera / Mielofibrosis Primaria Tipo de estudio: Diagnostic_studies Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google